Table 1. Patient characteristics and results | |||
Pre treatment | Post treatment | p value | |
FBS (mg/dl±SD) | 92.90±11.83 | 87.12±9.41 | <0.001* |
Free testosterone (ng/ml±SD) | 0.483±0.149 | 0.467±0.144 | 0.232 |
Insulin (mUI/l±SD) | 23.60±4.29 | 17.31±5.15 | <0.001* |
DHEA (micromol/l±SD) | 1.454±0.190 | 1.406±0.336 | 0.252 |
Ferriman–Gallwey score | 6.62±2.17 | 6.26±2.52 | 0.062 |
LDL (mg/dl±SD) | 169.47±32.7 | 152.47±32.19 | <0.001* |
HDL (mg/dl±SD) | 35.62±5.39 | 39.11±5.86 | <0.001* |
Triglycerides (mg/dl±SD) | 202.03±45.31 | 166.92±40.76 | <0.001* |
BMI (kg/m2±SD) | 28.28±2.6 | 26.82±2.46 | <0.001* |
Menstrual regularity (%) | 48.6 | 61.1 | <0.001* |
HOMA-IR | 96.22±18.18 | 67.04±22 | <0.001* |
* Statistically significant difference FBS: Fasting blood sugar, DHEA: Dehydroepiandrosterone LDL: Low-density lipoprotein, HDL: High-density lipoprotein, BMI: Body mass index SD: standard deviation |